How Big Is Vertex's News for Its Potential Diabetes Cure?

How Big Is Vertex's News for Its Potential Diabetes Cure?

Source: 
Motley Fool
snippet: 
  • Vertex announced encouraging results from a phase 1 study of VX-880 in treating type 1 diabetes (T1D).
  • The results, however, included just one patient with life-threatening T1D.
  • Vertex's bigger opportunity could be with its encapsulated cell therapy program targeting T1D.